“Some times I get up and may’t consider how much we’ve arrive,” said Dr. Doblin, 67, who now oversees the Multidisciplinary Association for Psychedelic Studies, a multimillion dollar investigate and advocacy empire that employs one hundred thirty neuroscientists, pharmacologists and regulatory professionals Doing work to put the groundwork